Cytotron, a therapeutic device to treat cancer , has been awarded a cash grant of a quarter million dollars by the US government.
The device known as Cytotron, developed by Indian scientist Dr Rajah Vijay Kumar, received the funding under the US Government’s Qualifying Therapeutic Discovery Project, which targets activities to treat cancer and improve drug targeting and delivery.
The device helps a protein called p53 to kill the potential cancer-causing cells at the right time and no side effects has been found in conventional treatments for cancer.
“Cancer is like a terrorist. Earlier , they were normal cells, which go haywire. All cells are programmed to die after some period . And when this doesn’t happen , we call it Cancer,” Dr Rajah Vijay Kumar, chief scientific officer at Scalene Cybernetics, an Indian Technology company, said.
Mr Kumar said that Cytotron can not only treat cancer, but also has the potential to treat diseases such as diabetes, Alzheimer’s disease and Parkinson’s disease. “Currently, there is no stand alone, whole body, multi-organ suitable therapeutic device in the market,” he said.
The device is also registered with ClinicalTrials.gov for a clinical trial of multiple Sclerosis. The clinical trials for Cancer and Osteoarthritis have been successfully completed at the Centre for Advanced Research and Development (CARD), the research and development wing of Scalene Cybernetics.
“The commercialisation potential of this technology which I have got patented runs into millions of dollars in markets such as the Europe and America,” said Mr Kumar, who started to work on Cytotron in 1987, but had to slow down due to lack of resources.
No comments:
Post a Comment